4.7 Article

Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 16, 页码 7285-7289

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm300564b

关键词

-

资金

  1. NIH/NCI [R01CA148706]
  2. GTx, Inc

向作者/读者索取更多资源

Novel ABI-III compounds were designed and synthesized based on our previously reported ABI-I and ABI-II analogues. ABI-III compounds are highly potent against a panel of melanoma and prostate cancer cell lines, with the best compound having an average IC50 value of 3.8 nM. They are not substrate of Pgp and thus may effectively overcome Pgp-mediated multidrug resistance. ABI-III analogues maintain their mechanisms of action by inhibition of tubulin polymerization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor

Zhongzhi Wu, Lubing Gu, Sicheng Zhang, Tao Liu, Pradeep B. Lukka, Bernd Meibohm, John C. Bollinger, Muxiang Zhou, Wei Li

Summary: The study reports a structurally optimized dual MDM2/XIAP inhibitor, leading to the discovery of a more potent analogue against EU-1, which exerts dual targeting effects and can induce cell death. The results suggest that the scaffold based on 14 shows promise for further development as a potential therapeutic agent for leukemia and other cancers.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

17,20S(OH)2pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model

Monica L. Brown Lobbins, Imara-Safi O. Scott, Andrzej T. Slominski, Karen A. Hasty, Sicheng Zhang, Duane D. Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Tejesh S. Patel, Linda K. Myers, Arnold E. Postlethwaite

Summary: The study shows that the noncalcemic vitamin D analog, 17,20S(OH)(2)pD, can suppress total collagen production, dermal thickness, and total collagen content in a fibrosis model, while also increasing MMP-13 expression and decreasing expression of other related factors, as well as suppressing certain cytokines in the serum. This antifibrotic property offers new therapeutic approaches for fibrotic disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy

Wen Shuai, Guan Wang, Yiwen Zhang, Faqian Bu, Sicheng Zhang, Duane D. Miller, Wei Li, Liang Ouyang, Yuxi Wang

Summary: Microtubules are crucial in cellular functions and important targets for cancer therapy, but drug resistance and toxicity limit their efficacy. Dual-target drugs, combining tubulin with other anti-tumor agents, are considered promising to overcome limitations and improve therapeutic efficacy. Rational target combinations and design strategies of dual-target tubulin inhibitors are discussed for future directions.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy

Hanxuan Li, Mohamed Moustafa Ibrahim, Hao Chen, Wei Li, Monica M. Jablonski

Summary: Glaucoma is a leading cause of permanent vision loss and current drugs are ineffective in halting the progression of the disease. Research has identified CACNA2D1 as a novel modulator of intraocular pressure (IOP) and validated the IOP-lowering effects of PRG and other compounds, providing potential new drug targets for treating glaucoma.

PHARMACEUTICALS (2021)

Article Chemistry, Medicinal

Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffold

Najah Albadari, Shanshan Deng, Hao Chen, Guannan Zhao, Junming Yue, Sicheng Zhang, Duane D. Miller, Zhongzhi Wu, Wei Li

Summary: The study describes the design and synthesis of a series of novel selective survivin inhibitors based on the hydroxyquinoline scaffold. The best compound identified, 12b, demonstrated potential anticancer activity by selectively targeting survivin and inducing cancer cell apoptosis. In vivo experiments showed that 12b effectively inhibited tumor growth and metastasis in melanoma and ovarian cancer models, suggesting promise for further preclinical development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Modulation by 17,20S(OH)2pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis

Monica L. Brown Lobbins, Andrzej T. Slominski, Karen A. Hasty, Sicheng Zhang, Duane D. Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Robert C. Tuckey, Imara-Safi O. Scott, Linda K. Myers, Arnold E. Postlethwaite

Summary: This study demonstrates that 17,20S(OH)(2)pD can suppress type I collagen synthesis and decrease the expression of fibrosis-related mediators, offering a potential noncalcemic secosteroidal therapeutic approach for treating systemic sclerosis and fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors

Rajib Bhuniya, Xinrui Yuan, Longchuan Bai, Kathryn L. Howie, Rui Wang, Wei Li, Frank Park, Chao-Yie Yang

Summary: CDC20 overexpression is associated with poor prognosis in breast and other cancers. By designing new CDC20 inhibitors and improving their chemical structure, the antitumor activity can be enhanced. The most effective inhibitor, 22, shows promise for further development.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Cell & Tissue Engineering

Beta-caryophyllene prevents the defects in trabecular bone caused by Vitamin D deficiency through pathways instated by increased expression of klotho

W. Dong, B. C. Postlethwaite, P. A. Wheller, D. Brand, Y. Jiao, W. Li, L. K. Myers, W. Gu

Summary: This study found that supplementing with beta-caryophyllene (BCP) can increase the serum levels of klotho in mice, leading to improved bone properties and mineralization.

BONE & JOINT RESEARCH (2022)

Article Oncology

Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+Breast Cancer and Metastasis

Raisa Krutilina, Kelli L. Hartman, Damilola Oluwalana, Hilaire C. Playa, Deanna N. Parke, Hao Chen, Duane D. Miller, Wei Li, Tiffany N. Seagroves

Summary: The study demonstrates the effectiveness of sabizabulin in inhibiting the growth and migration of HER2+ breast cancer cells, and inducing cell death. Sabizabulin is a promising alternative to taxanes for the treatment of HER2+ breast cancer, with similar anti-metastatic efficacy but better oral bioavailability and lower toxicity.

CANCERS (2022)

Review Biochemistry & Molecular Biology

Survivin Small Molecules Inhibitors: Recent Advances and Challenges

Najah Albadari, Wei Li

Summary: Survivin, a member of IAPs family, acts as a suppressor of apoptosis and is considered as an important cancer drug target due to its high expression in many types of human cancers. It is also involved in tumor cell resistance to chemotherapy and radiation. Downregulation of survivin can reduce tumor growth, induce apoptosis, and enhance tumor cell sensitivity to radiation and chemotherapy in different human tumor models.

MOLECULES (2023)

Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo

Satyanarayana Pochampally, Kelli L. Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur Parmar, Hyunseo Park, Bernd Meibohm, Stephen W. White, Wei Li, Duane D. Miller

Summary: A new compound that inhibits cancer cell proliferation has been discovered and shows high anticancer activity and a long half-life. It exhibits significant potency against a wide range of cancer cell lines and has the potential for further preclinical evaluation as a candidate for development.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Chemistry, Medicinal

Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold

Najah Albadari, Yang Xie, Tao Liu, Rui Wang, Lubing Gu, Muxiang Zhou, Zhongzhi Wu, Wei Li

Summary: This study designed and synthesized a series of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold and tested their cytotoxicity in human cancer cell lines. The compound 3e showed the best performance and effectively inhibited tumor growth in a 22Rv1 prostate cancer xenograft model. Overall, the results suggest that the tetrahydroquinoline scaffold has the potential for further preclinical development as a dual-targeting strategy for MDM2 and XIAP.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Pharmacology & Pharmacy

Antibody-drug conjugates: Recent advances in payloads

Zhijia Wang, Hanxuan Li, Lantu Gou, Wei Li, Yuxi Wang

Summary: Antibody-drug conjugates (ADCs) combine the advantages of monoclonal antibodies and drugs, showing great clinical potential. The payload of ADC drugs plays a crucial role in determining their efficacy, leading to significant research advancements and the development of novel efficient payloads with diverse targets and reduced side effects.

ACTA PHARMACEUTICA SINICA B (2023)

Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site- Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo

Satyanarayana Pochampally, Kelli L. Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur Parmar, Hyunseo Park, Bernd Meibohm, Stephen W. White, Wei Li, Duane D. Miller

Summary: By modifying the pyrimidine dihydroquinoxalinone scaffold, we discovered a new tubulin-polymerization inhibitor, compound 12k, that exhibited potent anticancer activity and significant tumor growth inhibition in vivo.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Cell & Tissue Engineering

Genetic interactions between polycystin-1 and Wwtr1 in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice

Zhousheng Xiao, Li Cao, Micholas Dean Smith, Hanxuan Li, Wei Li, Jeremy C. Smith, Leigh Darryl Quarles

Summary: This study demonstrates the interaction between polycystin-1 and Wwtr1 in osteoblasts and their role in mechanosensing and bone formation. The loss of both proteins results in greater reductions in bone mass and impaired mechanical loading responses. The findings suggest that PC1 and Wwtr1 form an anabolic mechanotransduction signaling complex and could be a potential therapeutic target for osteoporosis.

BONE RESEARCH (2023)

暂无数据